INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Market Access Planning_Getty-1482999252]( "2024 Market Trends In Clinical Trials: Navigating The Future With Ease")
2024 Market Trends In Clinical Trials: Navigating The Future With EaseExplore this year’s market trends survey for a comprehensive analysis of the emerging trends, evolving preferences, and key challenges set to shape the future of clinical trial processes.
-
![GettyImages-1439492413 patient recruitment]( "A Nimble And Flexible Solution To Rescuing An Observational Study")
A Nimble And Flexible Solution To Rescuing An Observational StudyUncover how a European biotech was able to accelerate site start-up and exceed patient recruitment goals at more than 145 sites in North America, Europe, and Asia Pacific (APAC).
-
![GettyImages-2095562171-data-tech-network]( "GSK And Medable Discuss The Next Phase Of DCTs")
GSK And Medable Discuss The Next Phase Of DCTsGSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
![iStock-1130696738-solution-child-patient-doctor-success]( "Proof-Of-Concept Study Enabled To Drive Novel Gene Therapy Program")
Proof-Of-Concept Study Enabled To Drive Novel Gene Therapy ProgramUnearth how a natural history trial aimed at addressing the exceptionally rare neurological disease affecting pediatric patients with no existing treatment options was executed successfully.
-
Defining 'Evidence Generation' Within Modern Clinical Trials1/26/2024
Learn how this distinctive approach centered on enabling clinical trial sponsors to gather data and generate evidence ensures the successful acquisition of diverse information.
-
Achieving Diversity In Clinical Trials Amidst Regulatory Focus5/23/2023
Learn about several strategies and best practices when enhancing diversity in clinical trials and advancing healthcare for all ethnic groups.
-
What Is The Secret To Ongoing TMF Health?8/22/2023
Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.
-
Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study4/17/2025
This randomized controlled pivotal phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for 3 consecutive weeks pre-surgery.
-
Non-Hodgkin Lymphoma – Global Clinical Trial Landscape - Focus On Asia Pacific9/12/2023
Gain a better understanding of the global clinical trial landscape of Non-Hodgkin lymphoma (NHL) and its trends in the Asia Pacific.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1600932692_doctor_data]( "Technology And Scientific Expertise To Power Your Program")
Learn how our expertise in eCOA, RTSM, and eConsent solutions can accelerate your drug development program from early phases to regulatory approval.
-
![GettyImages-1388184871-quality-compliance-approval]( "Reviewing Protocols Across Therapeutic Areas: BRANY IRB")
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
![GettyImages-1141567619 doctor patient]( "First In Human (FIH) Fact Sheet")
Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
-
![GettyImages-2156796837 cancer patient tablet]( "Why Leading Cancer Research Centers Trust OpenClinica For Oncology Trials")
See eight key reasons why leading cancer research centers rely on OpenClinica to navigate the intricacies of oncology trials and advance the field of cancer research.
-
![Medical Technology Data iStock-1185128095]( "Medidata AI Labs History")
Medidata Al Labs focuses on working closely with clients to answer important questions as they work to bring therapies to
patients faster.
